Jamjoom Pharma Declares SAR 2.20 Per Share Interim Dividend
JAMJOOM PHARMA 4015.SA | 0.00 |
On July 22, 2026, Jamjoom Pharmaceuticals Factory Company announced its Board of Directors' decision, made on July 21, 2026, to distribute interim cash dividends to shareholders for the first half of 2026. The total dividend amount is SAR 154,000,000, covering 70,000,000 eligible shares at SAR 2.20 per share, representing 22% of the share par value. The eligibility date is set for July 30, 2026, with dividends to be distributed on August 13, 2026. Non-resident foreign investors are advised that distributions are subject to a 5% withholding tax in accordance with applicable tax regulations.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=96925&anCat=1&cs=4015&locale=arNote: The original announcement does not explicitly specify a currency unit. Figures above are reproduced as-is. Please refer to the original announcement for details.
Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.
